Hanna, Nasser
Indiana University Health · Indiana University Indianapolis · Indiana University Melvin and Bren Simon Comprehensive Cancer Center · Indiana University School of Medicine
12 papers on CoChatORCID 0000-0002-7046-6426
Most cited papers
- Verified
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
Hanna, N., Shepherd, F. A., Fossella, F. V., Pereira, J. R., De Marinis, F., von Pawel, J., Gatzemeier, U., Tsao, T. C. Y., Pless, M., Muller, T., et al. (2004) · Journal of Clinical Oncology
Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment
Cited by 2,426
- Verified
The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies
Scagliotti, G., Hanna, N., Fossella, F., Sugarman, K., Blatter, J., Peterson, P., Simms, L., & Shepherd, F. A. (2009) · The Oncologist
Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment
Cited by 690
- Verified
Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Hanna, N., Johnson, D., Temin, S., Baker, S., Brahmer, J., Ellis, P. M., Giaccone, G., Hesketh, P. J., Jaiyesimi, I., Leighl, N. B., et al. (2017) · Journal of Clinical Oncology
Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment
Cited by 643
- Verified
A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)
Blumenschein, G. R., Smit, E. F., Planchard, D., Kim, D.-W., Cadranel, J., De Pas, T., Dunphy, F., Udud, K., Ahn, M.-J., Hanna, N. H., et al. (2015) · Annals of Oncology
Lung Cancer Treatments and MutationsLung Cancer Research Studies
Cited by 349
- Verified
Phase II Trial of Pembrolizumab in Patients with Platinum Refractory Germ-Cell Tumors: A Hoosier Cancer Research Network Study GU14-206
Adra, N., Einhorn, L. H., Althouse, S. K., Ammakkanavar, N. R., Musapatika, D., Albany, C., Vaughn, D., & Hanna, N. H. (2018) · Annals of Oncology
Testicular diseases and treatmentsCancer Immunotherapy and Biomarkers
Cited by 196
- Verified
Tobacco Cessation and Control a Decade Later: American Society of Clinical Oncology Policy Statement Update
Hanna, N., Mulshine, J., Wollins, D. S., Tyne, C., & Dresler, C. (2013) · Journal of Clinical Oncology
Smoking Behavior and CessationGlobal Public Health Policies and Epidemiology
Cited by 125
- Verified
Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers
Radovich, M., Kiel, P. J., Nance, S. M., Niland, E. E., Parsley, M. E., Ferguson, M. E., Jiang, G., Ammakkanavar, N. R., Einhorn, L. H., Cheng, L., et al. (2016) · Oncotarget
Cancer Genomics and DiagnosticsLung Cancer Treatments and Mutations
Cited by 111
- Verified
Acceptance and commitment therapy for symptom interference in advanced lung cancer and caregiver distress: a pilot randomized trial.
Mosher, C. E., Secinti, E., Hirsh, A. T., Hanna, N., Einhorn, L. H., Jalal, S. I., Durm, G., Champion, V. L., & Johns, S. A. (2019) · Journal of Pain and Symptom Management
Mindfulness and Compassion InterventionsCancer survivorship and care
Cited by 98
- Verified
Randomized pilot trial of a telephone symptom management intervention for symptomatic lung cancer patients and their family caregivers
Mosher, C. E., Winger, J. G., Hanna, N., Jalal, S. I., Einhorn, L. H., Birdas, T. J., Ceppa, D. P., Kesler, K. A., Schmitt, J., Kashy, D. A., et al. (2016) · Journal of Pain and Symptom Management
Cancer survivorship and careNursing care and research
Cited by 91
- Verified
Support service use and interest in support services among distressed family caregivers of lung cancer patients
Mosher, C. E., Champion, V. L., Hanna, N., Jalal, S. I., Fakiris, A. J., Birdas, T. J., Okereke, I. C., Kesler, K. A., Einhorn, L. H., Given, B. A., et al. (2013) · Psycho-Oncology
Nursing care and researchCancer survivorship and care
Cited by 65
- Verified
Phase II Trial of Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors
Ashkar, R., Feldman, D. R., Adra, N., Zaid, M. A., Funt, S. A., Althouse, S. K., Perkins, S. M., Snow, C. I., Lazzara, K. M., Sego, L. M., et al. (2021) · Investigational New Drugs
Testicular diseases and treatmentsLymphoma Diagnosis and Treatment
Cited by 16
- Verified
Relations of perceived injustice to psycho‐spiritual outcomes in advanced lung and prostate cancer: Examining the role of acceptance and meaning making
Secinti, E., Wu, W., Krueger, E. F., Hirsh, A. T., Torke, A. M., Hanna, N. H., Adra, N., Durm, G. A., Einhorn, L., Pili, R., et al. (2022) · Psycho-Oncology
Religion, Spirituality, and PsychologyCancer survivorship and care
Cited by 11
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free